Tema Etfs LLC Purchases 1,614 Shares of Intuitive Surgical, Inc. $ISRG

Tema Etfs LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,526 shares of the medical equipment provider’s stock after acquiring an additional 1,614 shares during the period. Tema Etfs LLC’s holdings in Intuitive Surgical were worth $4,262,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in ISRG. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Kilter Group LLC acquired a new stake in Intuitive Surgical during the second quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical during the third quarter worth approximately $27,000. Olistico Wealth LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, Caitlin John LLC bought a new stake in Intuitive Surgical in the third quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $464.45 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The business’s 50 day simple moving average is $490.34 and its two-hundred day simple moving average is $513.40. The firm has a market cap of $164.94 billion, a P/E ratio of 58.87, a PEG ratio of 3.56 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The company’s quarterly revenue was up 18.8% on a year-over-year basis. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. UBS Group cut their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a research note on Wednesday, March 11th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research report on Friday, January 23rd. BTIG Research reissued a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent fundamentals — Intuitive reported a strong quarter (EPS and revenue beats, healthy margins and ~19% year-over-year revenue growth), which underpins investor confidence in growth and helps justify the stock’s premium P/E.
• Positive Sentiment: Analyst / thematic support — Motley Fool coverage frames ISRG as a high-growth pick and highlights the company’s durable competitive position in surgical robotics, which can support longer-term investor demand. Intuitive Surgical Maintains Edge Despite Security Breach
• Neutral Sentiment: Recent trading moves — Coverage of ISRG’s intraday/settlement gains shows short-term buyer interest, but volume and market context suggest this is a continuation of momentum trading rather than a new fundamental catalyst. ISRG Rises But Trails Market
• Negative Sentiment: Security / operational risk — A phishing attack in March compromised an employee account and exposed some customer contact, employee and corporate information; this raises short-term reputational and operational risk and could pressure sentiment until controls and remediation are clearly communicated. Intuitive Surgical Maintains Edge Despite Security Breach
• Negative Sentiment: Analyst downgrade — Zacks cut ISRG from “strong-buy” to “hold,” which can reduce short-term buying pressure from model-driven funds and investor groups that track analyst sentiment. Zacks.com

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.